MIT Sloan logo MIT logo

Research


Wall Street’s Next Bet: Cures for Rare Diseases

2014

New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma, Inc.

2014
Journal of Investment Management
Sourya V. Naraharisetti

Financial Orphan Therapies Looking For Adoption

2014
Health Affairs Blog
Vikas Sukhatme, Kathy Fang, Vidula Sukhatme

Open-Source Software for “Financing Drug Discovery for Orphan Diseases”

2014
David E. Fagnan, Austin A. Gromatzky, Jose-Maria Fernandez, Roger M. Stein

Unintended Consequences of Expensive Cancer Therapeutics— The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity

2014
JAMA Otolaryngology-Head & Neck Surgery (2014)
Tito Fojo, Sham Mailankody

Parallel Discovery of Alzheimer’s Therapeutics

2014
Science Translational Medicine 241(6), 1-8
Carole Ho, Jayna Cummings, Kenneth S. Kosik

Open-Source Software for “Can Financial Engineering Cure Cancer?”

2013
David E. Fagnan, Jose Maria Fernandez, and Roger M. Stein

Can Financial Engineering Cure Cancer?

2013
American Economic Review 103 (2013), 406-411.
David E. Fagnan, Jose Maria Fernandez, and Roger M. Stein

Commercializing Biomedical Research through Securitization Techniques

2012
Nature Biotechnology 30 (2012), 964-975.
Jose-Maria Fernandez and Roger M. Stein

Open-Source Software for “Commercializing Biomedical Research through Securitization Techniques”

2012
Jose-Maria Fernandez and Roger M. Stein

© 2020 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.